Investigational product demonstrated superior hemodialysis vascular access outcomes compared with autologous arteriovenous ...

M any hemodialysis patients rely on central venous catheters, which can lead to dangerous bloodstream infections. A fistula is the preferable method, but it can be difficult to monitor. EchoMark is an ...

Thus, the creation of new dialysis machines must take into account all those features that might affect the final outcome, or at least contribute towards the concept of performing cardioprotective ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was ...

The cost of dialysis care is one of the leading medical expenditures of the federal government. This Canton startup is trying ...

Chronic kidney disease is a global public health problem, affecting about 10% of the world's population,1 with increasing ...

During the event, the surgeons will share case studies and highlight the V007 Phase 3 clinical results for Humacyte’s acellular tissue engineered vessel product candidate versus arteriovenous fistula, ...

Humacyte (HUMA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings ...

Shanice Wamboi, an 11-year-old Grade 6 student, is sitting for her KPSEA exams from Kenyatta University Referral Hospital due ...

A portion of the proceeds will support the ongoing evidence development for EchoMark and EchoSure, including the MAFASA trial ...

When Mark Iacono, owner of wood-fired-pizza institution Lucali in Carroll Gardens, learned his patron and friend Theo Alano, ...

Undergoing 10 hours of daily dialysis and being number 116,000 on the kidney transplant list haven’t deterred Kimball Croft ...